查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1714809

器官移植市場：按器官類型、產品類型、器官來源和最終用戶分類－2025-2030 年全球預測

Organ Transplantation Market by Type of Organ, Product Type, Source of Organs, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計器官移植市場規模到 2024 年將達到 181.1 億美元，到 2025 年將達到 199.1 億美元，到 2030 年將達到 326.5 億美元，複合年成長率為 10.31%。

主要市場統計數據
基準年2024年 181.1億美元
預計2025年 199.1億美元
預測年份 2030 326.5億美元
複合年成長率（%） 10.31%

器官移植是創新科學、卓越外科手術和富有同情心的護理的交匯點。近年來，該領域隨著技術的改進和新的臨床實踐取得了巨大進步。這項進展不僅改善了患者的治療效果，也擴大了器官移植的治療範圍。從第一次成功的器官移植到現代外科手術的歷程反映了醫學研究、監管發展和全球醫療保健策略的動態整合。隨著免疫抑制療法和外科手術技術的不斷進步，移植科室正受益於增強的方案，這些方案可最大限度地降低排斥風險，同時促進移植器官的長期存活。醫療保健專業人員、研究機構和生物技術公司之間的合作將確保最佳實踐在全球範圍內共用和整合，從而進一步推動這些發展。

隨著移植程序變得越來越複雜，需要全面了解當前趨勢和未來方向。分析師目前正在研究將資料分析與創新治療方法結合，以重新定義傳統實踐。這種變化的情況為改善患者照護提供了新的途徑。透過評估歷史成功和新興趨勢，相關人員可以深入了解器官移植領域面臨的多方面挑戰和機會。整合臨床專業知識、技術進步和醫療政策改革，創造出一種前瞻性的觀點，幫助決策者解決差距並在快速變化的環境中利用進步。

改變器官移植市場

隨著醫療技術的進步和患者照護需求的不斷變化，器官移植領域正在經歷一些變革時期。保守技術、微創手術和先進診斷工具的引入的現代突破重新定義了該領域的傳統界限。技術創新是這項轉變的核心。病患監測和器官灌注系統的顯著創新為延長儲存時間和改善移植物流鋪平了道路。

與此同時，監管格局也在改變。政府和衛生當局透過引入廣泛的框架來支持研究和簡化臨床核准，以應對日益成長的需求和病人安全問題。針對專業人士和一般大眾的教育舉措提高了人們對器官捐贈通訊協定的認知，從而擴大了可用器官的數量。同時，數位健康解決方案的整合促進了即時資料共用和遠端監控，使得患者結果的追蹤比以往更加動態。

這種轉變不僅對臨床實務產生影響，而且對各相關人員的經營模式也產生影響。公司正致力於研發創新解決方案，使植入更加可靠和有效率。科技、政策和患者照護之間的互動構成了持續改善的基礎，為更積極主動、反應迅速、專注於拯救生命的醫療保健服務系統奠定了基礎。

器官移植市場的關鍵細分洞察

深入研究市場區隔可以發現一些正在重塑器官移植策略和機會的關鍵見解。透過檢查器官類型、移植過程中涉及的產品類型、器官來源以及門診手術中心、醫院、專門移植中心等最終用戶等因素，行業相關人員可以識別利基市場並相應地客製化產品。

基於器官類型的分割的見解集中在廣泛的領域，從心臟移植到腎臟、肝臟、肺臟和胰臟移植手術。每個類別都有其獨特的臨床挑戰和技術需求，這推動了標靶治療的創新和投資。從產品類型來看，免疫抑制劑和支持關鍵手術的解決方案備受關注。從器官灌注系統到器官保存解決方案，以及手術器械和先進的移植診斷和監測能力，我們擁有突破品質和精確度界限的技術。

考慮器官的來源，區分死者移植和活體移植，增加了複雜性和機會。了解每種方法固有的細微差別對於設計針對患者的通訊協定至關重要。如此全面的細分將有助於識別市場需求，並使從臨床醫生到製造商的所有相關人員能夠在快速變化的環境中做出反映準確且可操作的見解的決策。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 慢性病增多導致器官衰竭和移植需求增加
      • 提高患者意識提升並在全球範圍內進行有效的器官捐贈宣傳活動
      • 支持性政府政策和法規結構加強器官捐贈系統
    • 限制因素
      • 移植費用高昂，器官捐贈者短缺
    • 機會
      • 增加對人體相容器官開發的投資和資金
      • 夥伴關係和協作激增，推動器官移植創新
    • 任務
      • 器官移植的副作用與安全風險
  • 市場區隔分析
    • 器官類型：捐贈者-接受者配對技術的不斷改進導致人們對腎臟移植的興趣日益濃厚。
    • 產品類型：移植後護理中對免疫抑制劑的需求不斷增加
    • 器官來源：在受控手術環境下對活體捐贈移植的興趣日益濃厚
    • 最終用戶：全面支援醫院的多器官移植服務
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章 器官移植市場（依器官類型）

  • 心臟移植
  • 腎臟移植
  • 肝臟移植
  • 肺移植
  • 胰臟移植

第7章 器官移植市場（依產品類型）

  • 免疫抑制劑
  • 器官灌注系統
  • 儲存解決方案
  • 手術器械及配件
  • 移植診斷與監測

第8章 器官移植市場（依器官來源）

  • 腦死捐贈者移植
  • 活體移植

第9章 器官移植市場（依最終用戶）

  • 門診手術中心
  • 醫院
  • 移植中心

第10章：美洲器官移植市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太器官移植市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲器官移植市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • 21st Century Medicine
  • Abbott Laboratories
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Bio-Rad Laboratories, Inc.
  • BiolifeSolutions, Inc.
  • Bridge to Life Ltd.
  • Bristol-Myers Squibb Company
  • CHIESI Farmaceutici SpA
  • Dr. Franz Kohler Chemie GmbH
  • eGenesis Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Medtronic PLC
  • Novartis AG
  • Organ Recovery Systems, Inc.
  • Organovo, Inc.
  • OrganOx Limited
  • Pfizer Inc.
  • Plexision, Inc.
  • Preservation Solutions, Inc.
  • Sanofi SA
  • Stryker Corporation
  • Terumo Corporation
  • Teva Pharmaceuticals Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • TransMedics Group, Inc.
  • United Therapeutics Corporation
  • Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp.
  • Vivalyx GmbH
  • Xvivo Perfusion AB
Product Code: MRR-437896AA3BAA

The Organ Transplantation Market was valued at USD 18.11 billion in 2024 and is projected to grow to USD 19.91 billion in 2025, with a CAGR of 10.31%, reaching USD 32.65 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 18.11 billion
Estimated Year [2025] USD 19.91 billion
Forecast Year [2030] USD 32.65 billion
CAGR (%) 10.31%

Organ transplantation stands at the intersection of innovative science, surgical excellence, and compassionate care. In recent years, the field has witnessed substantial advancements driven by technological refinement and new clinical practices. This evolution has not only improved patient outcomes but also broadened the therapeutic reach of organ transplantation. The journey from the first successful transplant to modern-day procedures reflects a dynamic blend of medical research, regulatory developments, and global healthcare strategies. As advances in immunosuppressive therapies and surgical techniques continue to surge, the transplantation sector benefits from enhanced protocols that minimize rejection risk while promoting long-term graft survival. Collaborations among healthcare professionals, research institutions, and biotechnology companies further propel these developments, ensuring that best practices are shared and integrated worldwide.

The growing complexity of transplant procedures necessitates a comprehensive understanding of current trends and future directions. Analysts are now focusing on integrating data analytics and innovative treatment modalities to redefine traditional practices. This transformed landscape creates new pathways for improving patient care. By evaluating historical successes and emerging trends, stakeholders gain insight into the multifaceted challenges and opportunities that lie ahead in the realm of organ transplantation. The synthesis of clinical expertise, technological progress, and healthcare policy reform is shaping a forward-thinking perspective, enabling decision-makers to address gaps and leverage advances in a rapidly mutating environment.

Transformative Shifts in the Organ Transplantation Landscape

The world of organ transplantation has undergone several transformative changes based on advancements in medical technology and evolving patient care needs. Modern breakthroughs in preservation techniques, minimally invasive surgery, and the introduction of sophisticated diagnostic tools have redefined the traditional boundaries of the field. Technological innovation is at the core of these shifts. Notable innovations in patient monitoring and organ perfusion systems have paved the way for extended preservation times and improved transplant logistics.

In parallel, the regulatory landscape has evolved. Governments and health authorities, responding to increasing demand and patient safety issues, have implemented expansive frameworks to support research and streamline clinical approvals. Educational initiatives aimed at both professionals and the public have increased awareness about organ donation protocols, thereby expanding the pool of available organs. At the same time, the integration of digital health solutions is facilitating real-time data sharing and remote monitoring, making it possible to track patient outcomes more dynamically than before.

This transformation affects not only clinical practice but also the business models of various stakeholders. Companies are redirecting their R&D efforts towards innovative solutions that enhance the reliability and efficiency of transplants. The interplay between technology, policy, and patient care forms the foundation for continued improvements, setting the stage for a more proactive and responsive healthcare delivery system focused on saving lives.

Key Segmentation Insights for the Organ Transplantation Market

A deep dive into market segmentation reveals several pivotal insights that are reshaping strategies and opportunities in organ transplantation. By examining factors such as the type of organ, the product type involved in the transplant process, the source of the organs, and the end-user-commonly represented by ambulatory surgical centers, hospitals, and specialized transplantation centers-industry stakeholders can identify niche markets and tailor their offerings accordingly.

Insight into segmentation based on the type of organ emphasizes areas ranging from heart transplantation to kidney, liver, lung, and pancreas transplant procedures. Each category presents unique clinical challenges and technological demands that drive innovation and investment in targeted therapies. Exploration based on product type demonstrates a keen focus on immunosuppressive drugs and solutions that support critical procedures. Technologies from organ perfusion systems to preservation solutions, along with surgical instruments and even advanced transplant diagnostics and monitoring capabilities, are pushing forward the envelope of quality and precision.

Consideration of the source of organs, which distinguishes between deceased donor transplantation and living donor transplantation, adds complexity and opportunity. Understanding the nuances inherent in each method has become crucial for designing patient-specific protocols. Such comprehensive segmentation enables the identification of market demands, ensuring that all stakeholders-from clinicians to manufacturers-can make decisions that reflect precise and actionable insights in an environment characterized by rapid change.

Based on Type of Organ, market is studied across Heart Transplantation, Kidney Transplantation, Liver Transplantation, Lung Transplantation, and Pancreas Transplantation.

Based on Product Type, market is studied across Immunosuppressive Drugs, Organ Perfusion Systems, Preservation Solutions, Surgical Instruments & Accessories, and Transplant Diagnostics & Monitoring.

Based on Source of Organs, market is studied across Deceased Donor Transplantation and Living Donor Transplantation.

Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Transplantation Centers.

Key Regional Insights in Organ Transplantation Trends

Regional dynamics within the organ transplantation market paint a complex picture, illustrating not only geographical disparities in access and infrastructure but also the distinct priorities and innovations emerging from each area. In the Americas, established healthcare systems are leveraging advanced surgical methods and comprehensive patient management strategies, which have resulted in enhanced procedural success rates and patient follow-up care. Investment in cutting-edge research and clinical trials is paving the way for continuous improvements in both patient outcomes and technological solutions.

The Europe, Middle East & Africa region exhibits a contrasting blend of innovation and evolving regulatory practices. While parts of Europe continue to push the envelope in terms of integrated healthcare delivery, other regions within this broader complex are focused on establishing robust organ donation programs and eliminating cultural barriers that impede donation rates. Our understanding of this region grows as policy reforms and collaborative research initiatives align with global best practices, fostering an environment ripe for both incremental and disruptive innovations.

In Asia-Pacific, economic dynamism and increasing investments in healthcare infrastructure are transforming the traditional landscape of organ transplantation. Rapid urbanization, greater government involvement, and rising healthcare awareness are driving significant strides in transplant technology and patient care protocols. The region's emphasis on digital health advancements and local manufacturing of sophisticated medical devices is contributing to its growing importance as a key player in the global organ transplantation market.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Vital Insights on Key Companies in the Transplantation Sector

Prominent companies in the organ transplantation sector are not only shaping the future of the field through innovation but also setting industry benchmarks for quality, reliability and cost efficiency. Market leaders such as 21st Century Medicine, Abbott Laboratories, and AbbVie Inc. have embarked on extensive research initiatives that address both the clinical and technological aspects of transplantation medicine. Simultaneously, industry innovators like Astellas Pharma Inc. and Bio-Rad Laboratories, Inc. are actively involved in breakthroughs that enhance patient management strategies and procedural outcomes.

Other influential companies, including BiolifeSolutions, Inc. and Bridge to Life Ltd., contribute specialized expertise that refines instrument precision and organ preservation techniques. Collaborations among global giants such as Bristol-Myers Squibb Company and CHIESI Farmaceutici S.p.A., along with technology-driven firms like eGenesis Inc. and F. Hoffmann-La Roche Ltd, highlight how integrated approaches can bridge gaps between surgical practice and advanced diagnostics.

Innovative contributions from other firms, for example, Illumina, Inc. and Medtronic PLC, underscore the importance of digital transformation and enhanced monitoring in the field. Companies such as Novartis AG as well as Organ Recovery Systems, Inc. and Organovo, Inc. are continuously pushing boundaries by incorporating cutting-edge research into clinical applications. Entities like OrganOx Limited, Pfizer Inc. and Plexision, Inc. further feature in advanced therapeutic and operational paradigms that have broader implications for both patient safety and hospital efficiencies. Additional market players-ranging from Preservation Solutions, Inc. and Sanofi S.A. to Stryker Corporation and Terumo Corporation-are shaping the competitive landscape alongside Teva Pharmaceuticals Industries Ltd., Thermo Fisher Scientific Inc., TransMedics Group, Inc. and United Therapeutics Corporation. Leaders such as Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp., Vivalyx GmbH and Xvivo Perfusion AB continue to drive innovation, reflecting a commitment to excellence and a deep understanding of market necessities across the transplantation spectrum.

The report delves into recent significant developments in the Organ Transplantation Market, highlighting leading vendors and their innovative profiles. These include 21st Century Medicine, Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bio-Rad Laboratories, Inc., BiolifeSolutions, Inc., Bridge to Life Ltd., Bristol-Myers Squibb Company, CHIESI Farmaceutici S.p.A., Dr. Franz Kohler Chemie GmbH, eGenesis Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Medtronic PLC, Novartis AG, Organ Recovery Systems, Inc., Organovo, Inc., OrganOx Limited, Pfizer Inc., Plexision, Inc., Preservation Solutions, Inc., Sanofi S.A., Stryker Corporation, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Thermo Fisher Scientific Inc., TransMedics Group, Inc., United Therapeutics Corporation, Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp., Vivalyx GmbH, and Xvivo Perfusion AB. Actionable Recommendations for Industry Leaders

It is essential for industry leaders to remain agile and forward-thinking in an environment characterized by rapid technological and regulatory changes. Continued investment in research and development should focus on pioneering treatment modalities while optimizing clinical pathways for maximum efficiency. At the strategic level, fostering cross-sector collaborations with academia and technology providers can accelerate the translation of innovations into clinically actionable insights.

Decision-makers should evaluate the dynamic shifts in both regional and global markets to tailor strategies that reflect evolving demographics and healthcare requirements. Embracing digital transformation and patient-centric approaches is not only a competitive necessity but a catalyst for improved patient outcomes. Companies are advised to monitor regulatory shifts closely and take proactive measures to harness new opportunities that arise from inter-sector partnerships and global initiatives.

Conclusion: Advancing the Future of Transplantation

In summary, the organ transplantation landscape continues to evolve, driven by technological advances, comprehensive segmentation insights, and dynamic regional influences. The synthesis of innovative research, strategic collaborations, and patient-centric care models is setting a promising precedent for future growth and enhanced transplantation outcomes. As stakeholders across the board invest in transformative technologies and regulatory reforms, the drive towards greater efficacy and improved patient care is more pronounced than ever.

The myriad challenges and opportunities that define the current environment are compelling industry leaders to embrace innovation and execute strategies that align with evolving global standards. By drawing on diverse insights and real-world data, stakeholders can develop robust frameworks that not only address immediate challenges but also pave the way for sustainable, long-term benefits in the field of organ transplantation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases contributing to organ failure and transplant demand
      • 5.1.1.2. Growing patient awareness and effective organ donation campaigns globally
      • 5.1.1.3. Supportive governmental policies and regulatory frameworks enhancing organ donation systems
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of transplantation procedures and shortage of available organ donors
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments & funding for the development of human-compatible organs
      • 5.1.3.2. Surging partnerships & collaborations to advance organ transplant innovation
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with side effects and safety in organ transplantation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type of Organ: Growing preference for kidney transplantation owing to continual refinement of donor-recipient matching technologies
    • 5.2.2. Product Type: Rising demand of immunosuppressive drugs for post-transplant care
    • 5.2.3. Source of Organs: Growing preference for living donor transplantation in controlled surgical settings
    • 5.2.4. End-User: Comprehensive support for multi-organ transplantation services in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Organ Transplantation Market, by Type of Organ

  • 6.1. Introduction
  • 6.2. Heart Transplantation
  • 6.3. Kidney Transplantation
  • 6.4. Liver Transplantation
  • 6.5. Lung Transplantation
  • 6.6. Pancreas Transplantation

7. Organ Transplantation Market, by Product Type

  • 7.1. Introduction
  • 7.2. Immunosuppressive Drugs
  • 7.3. Organ Perfusion Systems
  • 7.4. Preservation Solutions
  • 7.5. Surgical Instruments & Accessories
  • 7.6. Transplant Diagnostics & Monitoring

8. Organ Transplantation Market, by Source of Organs

  • 8.1. Introduction
  • 8.2. Deceased Donor Transplantation
  • 8.3. Living Donor Transplantation

9. Organ Transplantation Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals
  • 9.4. Transplantation Centers

10. Americas Organ Transplantation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Organ Transplantation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Organ Transplantation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FDA approves pig kidney transplant clinical trials by United Therapeutics and eGenesis, driving innovation in organ transplantation
    • 13.3.2. United Therapeutics receives FDA clearance for a 10 gene-edited pig kidney xenotransplantation trial
    • 13.3.3. Biocon's NMPA approval for tacrolimus capsules strengthens its organ transplantation portfolio and accelerates global market expansion
    • 13.3.4. Bridge to Life secures exclusive trademark for the VitaSmart hypothermic oxygenated machine perfusion system
    • 13.3.5. Biogen secures FDA designation for felzartamab, accelerating Phase 3 plans and transforming blood-driven antibody-mediated rejection treatment in kidney transplant recipients
    • 13.3.6. Natco Pharma acquires 40 million shares in eGenesis to accelerate xenotransplantation research to mitigate global organ shortages and improve transplant outcomes
    • 13.3.7. Getinge's announces an agreement to acquire Paragonix Technologies for digital innovation and global expansion in organ transplantation strategies
    • 13.3.8. Vivalyx secures EUR 5.4 million seed round to propel clinical trials and drive innovation in fully synthetic organ preservation for improved transplant outcomes
    • 13.3.9. Mayo Clinic and Terasaki Institute join forces to transform organ transplant outcomes with real-time health monitoring and predictive rejection assays
    • 13.3.10. Eledon Pharmaceuticals integrates investigational tegoprubart in a kidney xenotransplant procedure to enhance immunosuppression and improve long-term transplant outcomes
    • 13.3.11. X-Therma secures USD 22.4 million Series B funding to advance innovative cold chain technology for enhanced organ preservation
    • 13.3.12. TransMedics Signs Definitive Agreement to Acquire Summit Aviation to Expand TransMedics Aviation Capabilities for Organ Transplantation
    • 13.3.13. LiveOnNY and MediGO Collaborate to Launch Real-Time Organ Tracking Technology to Increase Transparency and Accountability Within the Organ Donation and Transplant Ecosystem
    • 13.3.14. PAHO and Spain Sign Agreement to Strengthen Organ Donation and Transplant in the Americas
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. United Therapeutics Corporation
    • 13.4.2. Pfizer Inc.
    • 13.4.3. Astellas Pharma Inc.
    • 13.4.4. AbbVie Inc.

Companies Mentioned

  • 1. 21st Century Medicine
  • 2. Abbott Laboratories
  • 3. AbbVie Inc.
  • 4. Astellas Pharma Inc.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. BiolifeSolutions, Inc.
  • 7. Bridge to Life Ltd.
  • 8. Bristol-Myers Squibb Company
  • 9. CHIESI Farmaceutici S.p.A.
  • 10. Dr. Franz Kohler Chemie GmbH
  • 11. eGenesis Inc.
  • 12. F. Hoffmann-La Roche Ltd
  • 13. Illumina, Inc.
  • 14. Medtronic PLC
  • 15. Novartis AG
  • 16. Organ Recovery Systems, Inc.
  • 17. Organovo, Inc.
  • 18. OrganOx Limited
  • 19. Pfizer Inc.
  • 20. Plexision, Inc.
  • 21. Preservation Solutions, Inc.
  • 22. Sanofi S.A.
  • 23. Stryker Corporation
  • 24. Terumo Corporation
  • 25. Teva Pharmaceuticals Industries Ltd.
  • 26. Thermo Fisher Scientific Inc.
  • 27. TransMedics Group, Inc.
  • 28. United Therapeutics Corporation
  • 29. Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp.
  • 30. Vivalyx GmbH
  • 31. Xvivo Perfusion AB

LIST OF FIGURES

  • FIGURE 1. ORGAN TRANSPLANTATION MARKET MULTI-CURRENCY
  • FIGURE 2. ORGAN TRANSPLANTATION MARKET MULTI-LANGUAGE
  • FIGURE 3. ORGAN TRANSPLANTATION MARKET RESEARCH PROCESS
  • FIGURE 4. ORGAN TRANSPLANTATION MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ORGAN TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. ORGAN TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ORGAN TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ORGAN TRANSPLANTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HEART TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY KIDNEY TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PANCREAS TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY IMMUNOSUPPRESSIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY ORGAN PERFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PRESERVATION SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY SURGICAL INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANT DIAGNOSTICS & MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY DECEASED DONOR TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVING DONOR TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. ORGAN TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 195. ORGAN TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2024